Both in Pharmaceuticals
Stoke Therapeutics vs ANI Pharmaceuticals
Over the past year STOK returned +4.7% and ANIP returned −21.0%; their daily moves had a correlation of 0.02.
STOK +4.7% ANIP −21.0%Growth of $1, one year, split-adjusted
| Metric | STOK | ANIP |
|---|---|---|
| Price | $25.88 | $72.62 |
| Market cap | $1.67B | $1.67B |
| Today | +1.49% | −2.95% |
| 1 month | −18.2% | −0.3% |
| 6 months | −18.5% | −1.5% |
| Year to date | −18.5% | −8.0% |
| 1 year | +7.2% | −22.0% |
| Revenue growth (YoY) | −32.5% | +25.9% |
| Gross margin | 100.0% | 62.4% |
| Net margin | −660.8% | 8.6% |
| P/E (TTM) | — | 16.7× |
| Price / sales | 60.5× | 1.7× |
| Net cash | $292.8M | -$234.7M |
| Dividend yield | — | — |
| Volatility (60d) | 47.2% | 30.1% |
| Short % of float | 22.7% | 13.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).